Qiagen (QGEN) Cash from Investing Activities (2010 - 2026)
Qiagen (QGEN) posted Cash from Investing Activities of $211.5 million for Q1 2026, up 169.34% sequentially from -$305.0 million in Q4 2025, and up 76.11% YoY from $120.1 million in Q1 2025.
Qiagen (QGEN) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Qiagen has reported Cash from Investing Activities for 16 years, with the latest figure at $211.5 million in Q1 2026.
- Quarterly Cash from Investing Activities rose 76.11% year-over-year to $211.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$292.4 million (up 22.63% YoY) and the FY2025 annual result came in at -$305.3 million, down 22.49% from the prior year.
- Cash from Investing Activities grew to $211.5 million in Q1 2026 per QGEN's latest filing, from -$305.0 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $248.4 million in Q3 2023 and troughed at -$727.0 million in Q4 2022.
- A 5-year average of -$124.1 million and a median of -$88.0 million in 2023 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities slumped 388.99% in 2022, then surged 1767.22% in 2025.
- Over 5 years, Cash from Investing Activities stood at -$727.0 million in 2022, then jumped by 87.9% to -$88.0 million in 2023, then sank by 182.95% to -$249.0 million in 2024, then decreased by 22.49% to -$305.0 million in 2025, then jumped by 169.34% to $211.5 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered $211.5 million, -$305.0 million, and -$156.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 164.00 Mn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -10.15 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -25.50 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -77.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -381.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -32.14 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -122.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -1.94 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -134.00 Mn |
| 10 | Qiagen | 8.65 Bn | 8.65 Bn | - | 211.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 211.47 Mn |
| Mar 31, 2026 | 211.47 Mn |
| Dec 31, 2025 | -305.00 Mn |
| Dec 31, 2025 | -305.00 Mn |
| Sep 30, 2025 | -156.90 Mn |
| Sep 30, 2025 | -156.90 Mn |
| Jun 30, 2025 | -42.00 Mn |
| Jun 30, 2025 | -42.00 Mn |
| Mar 31, 2025 | 120.08 Mn |
| Mar 31, 2025 | 120.08 Mn |
| Dec 31, 2024 | -249.00 Mn |
| Dec 31, 2024 | -249.00 Mn |
| Sep 30, 2024 | -231.04 Mn |
| Sep 30, 2024 | -231.04 Mn |
| Jun 30, 2024 | -18.00 Mn |
| Jun 30, 2024 | -18.00 Mn |
| Mar 31, 2024 | 6.43 Mn |
| Mar 31, 2024 | 6.43 Mn |
| Dec 31, 2023 | -88.00 Mn |
| Dec 31, 2023 | -88.00 Mn |